Amir Avan

12.5k total citations
344 papers, 9.1k citations indexed

About

Amir Avan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Amir Avan has authored 344 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Molecular Biology, 87 papers in Oncology and 67 papers in Cancer Research. Recurrent topics in Amir Avan's work include MicroRNA in disease regulation (38 papers), Cancer-related molecular mechanisms research (33 papers) and Circular RNAs in diseases (25 papers). Amir Avan is often cited by papers focused on MicroRNA in disease regulation (38 papers), Cancer-related molecular mechanisms research (33 papers) and Circular RNAs in diseases (25 papers). Amir Avan collaborates with scholars based in Iran, United Kingdom and United States. Amir Avan's co-authors include Seyed Mahdi Hassanian, Gordon A. Ferns, Majid Khazaei, Soodabeh Shahidsales, Afsane Bahrami, Majid Ghayour‐Mobarhan, Mina Maftouh, Mikhail Ryzhikov, Majid Ghayour‐Mobarhan and Farzad Rahmani and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Amir Avan

334 papers receiving 9.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir Avan Iran 50 4.6k 2.4k 1.9k 899 875 344 9.1k
Frank Arfuso Australia 56 5.5k 1.2× 1.7k 0.7× 1.8k 0.9× 775 0.9× 867 1.0× 131 10.2k
Li Li China 48 4.7k 1.0× 1.4k 0.6× 2.1k 1.1× 731 0.8× 1.2k 1.4× 420 9.9k
Ioana Berindan‐Neagoe Romania 52 5.6k 1.2× 3.7k 1.6× 1.1k 0.6× 591 0.7× 538 0.6× 351 9.3k
Shu Zhang China 47 4.6k 1.0× 1.8k 0.8× 1.9k 1.0× 527 0.6× 1.2k 1.4× 351 9.6k
Rohit Srivastava United States 61 7.3k 1.6× 1.8k 0.7× 2.6k 1.4× 1.3k 1.5× 1.1k 1.3× 206 12.0k
Lu Zhang China 47 6.0k 1.3× 2.8k 1.2× 1.2k 0.7× 364 0.4× 647 0.7× 383 9.5k
Rong Li China 46 4.5k 1.0× 1.5k 0.6× 2.2k 1.2× 351 0.4× 704 0.8× 454 8.8k
Jack L. Arbiser United States 62 5.6k 1.2× 1.5k 0.6× 2.3k 1.2× 664 0.7× 903 1.0× 246 12.6k
Hui Liu China 46 6.2k 1.3× 1.6k 0.7× 1.9k 1.0× 751 0.8× 956 1.1× 447 11.5k
Laura J. Niedernhofer United States 61 7.9k 1.7× 2.0k 0.8× 1.1k 0.6× 1.2k 1.3× 819 0.9× 168 13.8k

Countries citing papers authored by Amir Avan

Since Specialization
Citations

This map shows the geographic impact of Amir Avan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Avan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Avan more than expected).

Fields of papers citing papers by Amir Avan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Avan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Avan. The network helps show where Amir Avan may publish in the future.

Co-authorship network of co-authors of Amir Avan

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Avan. A scholar is included among the top collaborators of Amir Avan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Avan. Amir Avan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Afshari, Asma, et al.. (2025). Review of potential anti-cancer properties of lactobacilli against breast cancer. Future Oncology. 22(5). 595–603. 1 indexed citations
2.
Rouzbahani, Arian Karimi, et al.. (2024). Machine learning algorithms and biomarkers identification for pancreatic cancer diagnosis using multi-omics data integration. Pathology - Research and Practice. 263. 155602–155602. 4 indexed citations
3.
Vahedi, Ehsan, et al.. (2024). Advancing Novel Strategies against Post-surgical Tendon Adhesion Bands,Exploring New Frontiers. Current Pharmaceutical Design. 30(21). 1650–1658. 2 indexed citations
4.
Hassanian, Seyed Mahdi, Ladan Goshayeshi, Mohammad Reza Abbaszadegan, et al.. (2024). G-Protein Signaling Modulator 2 as a Potential Biomarker in Colorectal Cancer: Integrative Analysis Using Genetic Profiling and Pan-Cancer Studies. Genes. 15(4). 474–474. 1 indexed citations
5.
Zaffaroni, Nadia, Carlotta Granchi, Filippo Minutolo, et al.. (2023). Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma. International Journal of Molecular Sciences. 24(9). 7771–7771. 13 indexed citations
6.
Pourali, Ghazaleh, Hamid Fiuji, Hamid Tanzadehpanah, et al.. (2023). Therapeutic Potential of Targeting the Cytochrome P450 Enzymes Using Lopinavir/Ritonavir in Colorectal Cancer: A Study in Monolayers, Spheroids and In Vivo Models. Cancers. 15(15). 3939–3939. 5 indexed citations
7.
Bononi, Giulia, Giulio Poli, Gabriella Ortore, et al.. (2022). Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives. Journal of Medicinal Chemistry. 65(10). 7118–7140. 11 indexed citations
8.
Sahebi, Reza, Hamideh Ghazizadeh, Amir Avan, et al.. (2021). Association between a genetic variant in scavenger receptor class B type 1 and its role on codon usage bias with increased risk of developing coronary artery disease. Clinical Biochemistry. 95. 60–65. 3 indexed citations
9.
Soleimani, Atena, Farzad Rahmani, Gordon A. Ferns, et al.. (2019). Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer. Current Pharmaceutical Design. 24(39). 4605–4610. 23 indexed citations
10.
Darroudi, Susan, Amir Tajbakhsh, Habibollah Esmaily, et al.. (2019). 50 bp deletion in promoter superoxide dismutase 1 gene and increasing risk of cardiovascular disease in Mashhad stroke and heart atherosclerotic disorder cohort study. BioFactors. 46(1). 55–63. 10 indexed citations
11.
Moradi‐Marjaneh, Reyhaneh, et al.. (2018). Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer. Current Pharmaceutical Design. 24(23). 2710–2718. 9 indexed citations
12.
Avan, Amir, Seyedeh Belin Tavakoly Sany, Majid Ghayour‐Mobarhan, et al.. (2018). Serum C‐reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice. Journal of Cellular Physiology. 233(11). 8508–8525. 140 indexed citations
13.
Tajfard, Mohammad, Seyedeh Belin Tavakoly Sany, Amir Avan, et al.. (2018). Relationship between serum high sensitivity C‐reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors. Journal of Cellular Physiology. 234(7). 10289–10299. 32 indexed citations
14.
Shahidsales, Soodabeh, et al.. (2018). Clinicopathologic Features and Survival of Breast Cancer Subtypes in Northeast Iran. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Moradi, Ali, Faezeh Ghasemi, Kazem Anvari, et al.. (2018). Association of Epstein-Barr virus with Esophageal Squamous Cell Carcinoma. SHILAP Revista de lepidopterología. 2 indexed citations
16.
Javadinia, Seyed Alireza, Mona Joudi Mashhad, Gordon A. Ferns, et al.. (2018). Anti‐tumoral effects of low molecular weight heparins: A focus on the treatment of esophageal cancer. Journal of Cellular Physiology. 233(10). 6523–6529. 19 indexed citations
17.
Kermani, Ali, Sare Hosseini, Mona Joudi Mashhad, et al.. (2018). A randomized clinical trial on the antitumoral effects of low molecular weight heparin in the treatment of esophageal cancer. Journal of Cellular Physiology. 234(4). 4191–4199. 24 indexed citations
18.
Ebrahimi, Safieh, et al.. (2016). Effects of Ramadan Fasting on the Regulation of Inflammation. SHILAP Revista de lepidopterología. 5 indexed citations
19.
Ghasemi, Farhad, et al.. (2016). Prognostic and Predictive Values of MicroRNAs in Pancreatic Cancer. 1(1). 1 indexed citations
20.
Avan, Amir, Seyed Reza Mirhafez, Amir Tajbakhsh, et al.. (2015). Impact of the C1431T Polymorphism of the Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ) Gene on Fasted Serum Lipid Levels in Patients with Coronary Artery Disease. Annals of Nutrition and Metabolism. 66(2-3). 149–154. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Arfuso Breakdown of academic impact, for papers by Li Li Breakdown of academic impact, for papers by Ioana Berindan‐Neagoe Breakdown of academic impact, for papers by Shu Zhang Breakdown of academic impact, for papers by Rohit Srivastava Breakdown of academic impact, for papers by Lu Zhang Breakdown of academic impact, for papers by Rong Li Breakdown of academic impact, for papers by Jack L. Arbiser Breakdown of academic impact, for papers by Hui Liu Breakdown of academic impact, for papers by Laura J. Niedernhofer
Rankless by CCL
2026